Clinical Trials Directory

Trials / Completed

CompletedNCT01301469

Comparison of HES 130 in Balanced and in Unbalanced Solution

Prospective, Randomized, Double-blind, Controlled, Multicenter Study on the Efficacy and Safety of HES 130/0. 42 in a Balanced Electrolyte Solution vs a HES 130/0.4 in a Sodium Chloride Solution in Elective Surgery Patients

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
240 (actual)
Sponsor
B. Braun Melsungen AG · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the efficacy of HES 130/0.42 in an electrolyte infusion in comparison to HES 130/0.4 in a sodium chloride infusion.

Conditions

Interventions

TypeNameDescription
DRUG6% HES 130/0.42 in plasma adapted Ringer's solution60 g/l hydroxyethyl starch 130 dissolved in plasma adapted Ringer's solution (balanced solution)
DRUG6% HES 130/0.4 in a saline solution60 g/l Hydroxyethyl starch (HES) with a mean molecular weight of 130 kDalton which is dissolved in a saline solution

Timeline

Start date
2011-02-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2011-02-23
Last updated
2012-01-05

Locations

4 sites across 1 country: China

Source: ClinicalTrials.gov record NCT01301469. Inclusion in this directory is not an endorsement.